← SynDRA
BALAPIRAVIR
SynDRA canonical compound SYN0019823 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
| Mechanism of action | RNA polymerase inhibitor |
All known targets
Mechanisms of action (all sources)
- RNA polymerase inhibitor
- Inhibitor
Cross-references
Synonyms
- R-1626
- R1626
- RO-4588161
- RO4588161
- Balapiravir hydrochloride
- HCV NS5B polymerase inhibitor, Roche
- RO4588161-001
- RNA polymerase inhibitor (HCV infection), Roche
- RNA polymerase inhibitor (hepatitis C infection), Roche
- R-1479 prodrug (HCV infection), Roche
- 4'-C-Azidocytidine 2',3',5'-tris(2-methylpropanoate)
- Ro 4588161
- (2R,3S,4R,5R)-5-(4-amino-2-oxopyrimidin-1(2H)-yl)-2-azido-2-((isobutyryloxy)methyl)tetrahydrofuran-3,4-diyl bis(2-methylpropanoate)
- Balapiravir [USAN]
- VOT0LP7I9K
- BALAPIRAVIR [INN]
- BALAPIRAVIR [WHO-DD]
- Cytidine, 4'-C-azido-, 2',3',5'-tris(2-methylpropanoate)
- CHEMBL550936
- SCHEMBL13592072
- DTXSID40219098
- ZINC35328439
- CS-0369
- DB12283
- NCGC00378751-01
- HY-10443
- Q17070900
- [(2R,3S,4R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-2-azido-3,4-bis(2-methylpropanoyloxy)oxolan-2-yl]methyl 2-methylpropanoate
- 4-AMINO-1-(4-C-AZIDO-2',3',5'-TRI-O-(2-METHYLPROPANOYL)-.BETA.-D-RIBOFURANOSYL)PYRIMIDIN- 2(1H)-ONE
- R 1626
- balapiravirum
- RefChem:916692
- DTXCID60141589
- C21H30N6O8
- Ro 4588161;R1626
- orb1707596
- EX-A12382
- MFCD18251433
Look up BALAPIRAVIR in the interactive SynDRA portal →